诚意药业
(603811)
| 流通市值：31.48亿 | | | 总市值：31.48亿 |
| 流通股本：4.58亿 | | | 总股本：4.58亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 431,793,470.88 | 200,996,487.21 | 812,349,118.11 | 597,031,023.17 |
| 营业收入 | 431,793,470.88 | 200,996,487.21 | 812,349,118.11 | 597,031,023.17 |
| 二、营业总成本 | 330,239,717.13 | 155,775,268.01 | 638,046,793.58 | 459,087,621.87 |
| 营业成本 | 125,933,912.48 | 60,388,379.17 | 245,335,524.13 | 173,384,209.12 |
| 税金及附加 | 8,266,037.95 | 3,925,614 | 16,059,493.93 | 12,011,074.5 |
| 销售费用 | 104,670,336.97 | 44,790,436.58 | 195,733,232.04 | 150,731,663.36 |
| 管理费用 | 67,720,216.5 | 33,649,803.51 | 132,470,636.52 | 87,376,552.45 |
| 研发费用 | 23,224,235.34 | 12,818,416.63 | 44,438,240.4 | 31,911,748.38 |
| 财务费用 | 424,977.89 | 202,618.12 | 4,009,666.56 | 3,672,374.06 |
| 其中:利息费用 | 390,684.76 | 212,330.06 | 3,831,389.8 | 3,495,325.71 |
| 其中:利息收入 | 154,135 | 40,809.99 | 233,974.56 | 174,477.11 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | 11,133,800.3 | 3,771,221.64 | 33,093,574.46 | 28,104,091.41 |
| 资产处置收益 | 1,263,594.29 | 1,263,594.29 | 21,064,523.22 | 111,916.62 |
| 资产减值损失(新) | -4,311,636.47 | -643,112.72 | -11,737,649.89 | -6,148,331.99 |
| 信用减值损失(新) | -538,236.95 | -941,285.35 | 644,123.5 | -139,807.22 |
| 其他收益 | 2,969,483.12 | 1,631,251.98 | 7,234,572.61 | 4,546,450.21 |
| 四、营业利润 | 112,070,758.04 | 50,302,889.04 | 224,601,468.43 | 164,417,720.33 |
| 加:营业外收入 | 70,697.47 | 23,469.32 | 252,298.78 | 174,625.65 |
| 减:营业外支出 | 408,277.92 | 64,402.11 | 1,011,610.04 | 719,776.26 |
| 五、利润总额 | 111,733,177.59 | 50,261,956.25 | 223,842,157.17 | 163,872,569.72 |
| 减:所得税费用 | 15,980,984.93 | 5,638,185.43 | 26,376,950.11 | 19,265,997.25 |
| 六、净利润 | 95,752,192.66 | 44,623,770.82 | 197,465,207.06 | 144,606,572.47 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 95,752,192.66 | 44,623,770.82 | 197,465,207.06 | 144,606,572.47 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 94,868,692.24 | 44,289,745.45 | 195,116,716.86 | 142,723,526.51 |
| 少数股东损益 | 883,500.42 | 334,025.37 | 2,348,490.2 | 1,883,045.96 |
| 扣除非经常损益后的净利润 | 92,445,871.64 | 42,463,983.12 | 173,880,085.66 | 140,386,721.11 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.21 | 0.14 | 0.61 | 0.45 |
| (二)稀释每股收益 | 0.21 | 0.14 | 0.61 | 0.45 |
| 九、综合收益总额 | 95,752,192.66 | 44,623,770.82 | 197,465,207.06 | 144,606,572.47 |
| 归属于母公司股东的综合收益总额 | 94,868,692.24 | 44,289,745.45 | 195,116,716.86 | 142,723,526.51 |
| 归属于少数股东的综合收益总额 | 883,500.42 | 334,025.37 | 2,348,490.2 | 1,883,045.96 |
| 公告日期 | 2026-08-27 | 2026-04-24 | 2026-04-24 | 2025-10-28 |
| 审计意见(境内) | | | 标准无保留意见 | |